Skip to content

Mindfulness-Based Substance Use Prevention (MINDS-UP)

Mindfulness-Based Substance Use Prevention (MINDS-UP): a Randomized Controlled Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06593470
Acronym
MINDS-UP
Enrollment
45
Registered
2024-09-19
Start date
2026-10-01
Completion date
2028-01-01
Last updated
2026-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Substance Use

Brief summary

The goal of this clinical trial is to test the feasibility, behavioral/neural mechanisms, and preliminary efficacy of "MINDfulness-based Substance Use Prevention Program," or "MINDS-UP", a novel substance use prevention meditation intervention for children and adolescents between the ages of 10 and 14. The main questions it aims to answer are: 1. Is MINDS-UP feasible and what is its preliminary efficacy? 2. Are MRI protocol and procedures feasible? An additional exploratory question is: Are there neural and psychopathological mechanisms through which MINDS-UP might work? Researchers will compare Sport - Prevention Plus Wellness (PPW) (an evidence based substance use prevention program) to Sport - Prevention Plus Wellness + MINDS-UP to examine the preliminary efficacy of MINDS-UP. Participants will * take assessment #1 * have 2 MRIs and take MINDS-UP, just take MINDS-UP or have a delayed start * take assessment #2 * take PPW, a single remote and research assistant-delivered 45-minute session * take assessment #3 * take assessment #4

Interventions

BEHAVIORALMINDS-UP

MINDS-UP is a substance use prevention program for children/adolescents.It consists of 4 x 60-minute sessions, once weekly over 4 weeks. The four MINDS-UP classes will focus on the following: Mindfulness of Body; Mindfulness of Mind; Mindfulness of Environment/Community; Kindness, Compassion, Joy and Equanimity, respectively.

BEHAVIORALPrevention Plus Wellness

PPW is a standardized, empirically-based intervention for substance use prevention in adolescents ages 10-14. It consists of 1 45-60 minute session between an adolescent and a trained PPW teacher.

DIAGNOSTIC_TESTfMRI

Functional MRI to investigate preliminary neural mechanisms of MINDS-UP

Sponsors

New York State Psychiatric Institute
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 14 Years
Healthy volunteers
Yes

Inclusion criteria

* Youth is ages 10-14 years on the day of screening \[i.e., does not turn 15 before or on the day of screening\] * Access to a smart phone, tablet, or computer with Wi-Fi * English-speaking

Exclusion criteria

* Has been diagnosed with or received treatment for one of the following mental health problems: depression, bipolar disorder, schizophrenia, autism spectrum disorder, intellectual disability, or substance use disorder. * Youth is actively involved in another Boricua Youth Study (BYS) * Youth's sibling is or has previously been enrolled in MINDS-UP.

Design outcomes

Primary

MeasureTime frameDescription
Teacher Rated ParticipationCompletion of Study (up to 36 months)Research Assessment Package for Schools - Teacher Rated
AcceptabilityCompletion of Study (up to 36 months)Acceptability of Intervention Measure
RetentionCompletion of Study (up to 36 months)Percent of participants who completed all study procedures among those who were randomized
AttendanceCompletion of Study (up to 36 months)Percent of scheduled sessions that were completed by the participant.
Homework CompletionCompletion of Study (up to 36 months)Percentage of assigned homeworks that were completed by the participant.
Participation (student)Completion of Study (up to 36 months)Research Assessment Package for Schools - Student Engagement

Secondary

MeasureTime frameDescription
MRI retentionCompletion of Study (up to 36 months)Percentage of participants randomized to receive MRI that complete both MRIs
Future MRI endorsementCompletion of Study (up to 36 months)Percentage of participants who endorse willingness to undergo a future research MRI scan
Anxiety and Depression4-6 weeks, 6 months, and 12 monthsPre-assessment to post-assessment (and 6 and 12 month-follow-up) difference in score on the Revised Childhood Anxiety and Depression scale, a 47-item self-report scale that assesses childhood/adolescent anxiety and depression symptoms across six sub-domains.
Mindfulness4-6 weeks, 6 months, and 12 monthsPre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the Child and Adolescent Mindfulness Measure (CAMM); the CAMM is a 10-item measure of self-reported mindfulness; scores range from 0 to 40, with higher scores indicating higher mindfulness
Externalizing Problems (parent-report)4-6 weeks, 6 months, and 12 monthsPre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the externalizing problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 33 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of externalizing problems
Externalizing Problems (self-report)4-6 weeks, 6 months, and 12 monthsPre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the externalizing problems subscale on the Youth Self Report, which is comprised of 112 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems
Total Problems (self-report)4-6 weeks, 6 months, and 12 monthsPre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the total problems subscale Youth Self Report; the survey is comprised of 112 items, with individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems
Total Problems (parent-report)4-6 weeks, 6 months, and 12 monthsPre-assessment to post-assessment (and 6- and 12-month follow-up) difference in the total score on the total problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 98 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of behavioral problems
Cannabis Use4-6 weeks, 6 months, and 12 monthsCannabis use as measured by the Marijuana Low-Level Use Measure, a short tool that measures early/first use of cannabis.
Alcohol sipping4-6 weeks, 6 months, and 12 monthsLow-level and early alcohol use as characterized by the iSay Sipping Inventory. This survey characterizes low level and first/early alcohol use, including age at first sip, whether that drink was completed, and behaviors after the first sip.
Tobacco Use4-6 weeks, 6 months, and 12 monthsTobacco use as measured by Tobacco Low Level Use Measure. This is a short tool that measures number of times used, type of tobacco/nicotine used, duration of use, and frequency of use.
ADHD Symptoms4-6 weeks, 6 months, and 12 monthsPre-assessment to post-assessment (and 6- and 12-month follow-up) difference in score on the externalizing problems subscale on the Child Behavior Checklist (CBCL), which is comprised of 33 questions; individual item scores range from 0 to 2; higher scores indicate higher amount of externalizing problems

Contacts

CONTACTDavid C Saunders, MD, PhD
david.saunders@nyspi.columbia.edu914-409-6807

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 25, 2026